HepaRegeniX Secures €15M Series C Funding to Advance Liver Regeneration Therapy HRX-215

Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regeneration Elias Pa...

July 10, 2024 | Wednesday | News
Epsilogen Receives MHRA Approval for Phase Ib Trial of MOv18 IgE in Treating Platinum-Resistant Ovarian Cancer

Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that the Clinical Trial Application f...

July 09, 2024 | Tuesday | News
Apriori Bio Secures $1.1 Million from CEPI to Enhance AI-Driven Vaccine Platform Against Evolving Viruses

Biotechnology company Apriori Bio has been awarded US $1.1 million from CEPI to advance its biology-informed artificial intelligence platform Octavi...

July 09, 2024 | Tuesday | News
Eli Lilly to Acquire Morphic Holding for $3.2 Billion, Expanding Gastroenterology Portfolio

Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF)  announced a definitive agreement for Lilly to acquire Mor...

July 09, 2024 | Tuesday | News
Vertex Pharmaceuticals' Vanza Triple Granted Priority Review by FDA with Target Action Date of January 2, 2025

Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorizat...

July 03, 2024 | Wednesday | News
FDA Approves Eli Lilly's Kisunla™ for Early Symptomatic Alzheimer's Disease

Kisunla slowed cognitive and functional decline by up to 35% compared to placebo at 18 months in its pivotal Phase 3 study and reduced participants' risk...

July 03, 2024 | Wednesday | News
Biogen Inc. Completes Acquisition of Human Immunology Biosciences (HI-Bio™)

Biogen Inc. has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company foc...

July 03, 2024 | Wednesday | News
Merck and and Orion Announce Exercise of Option for Exclusive Global License of Opevesostat, Advancing Prostate Cancer Treatment

Merck  known as MSD outside of the United States and Canada, and Orion Corporation announced that notice has been provided of the mutual exercise of...

July 02, 2024 | Tuesday | News
Dawn Health Partners with Merck to Develop Digital Solution for Growth Hormone Disorders

Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, M...

July 01, 2024 | Monday | News
Moderna’s mRESVIA Receives Positive CHMP Opinion for RSV Vaccine in Adults 60+

Moderna,  announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion ...

July 01, 2024 | Monday | News
Bio-Rad Launches Celselect Slides 2.0 to Enhance Rare Cell and CTC Capture

Bio-Rad Laboratories,  a global leader in life science research and clinical diagnostics products, today announced the launch of Celselect Slides 2....

July 01, 2024 | Monday | News
AbbVie Acquires Celsius Therapeutics to Advance Innovative IBD Treatments

AbbVie (NYSE: ABBV) announced  the acquisition of Celsius Therapeutics, Inc. ("Celsius"), a privately held biotechnology company pioneering new...

June 28, 2024 | Friday | News
Thermo Fisher Scientific’s PPD Clinical Research Business to Expand Kentucky Labs, Adding Over 250 Jobs

The PPD clinical research business will nearly double its laboratory footprint in northern Kentucky, add more than 250 jobs The PPD clinical research bu...

June 28, 2024 | Friday | News
WHO Awards Prequalification to Roche's HPV Test for Broad Use, Enhancing Global Cervical Cancer Screening

The World Health Organization (WHO) has awarded Roche's human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System ...

June 27, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close